News
Video
Compounded GLP-1 RA drugs: Criteria for compounding medicines to fill gaps that drugmakers can’t fill
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
There are three criteria for compounding pharmacists to mix a version of a medicine that is not available from a pharmaceutical manufacturer. Scott Brunner, CEO of the Alliance for Pharmacy Compounding offers this tutorial and examples of how compounding pharmacists meet patient demand for necessary drugs.
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
Related Videos
Related Content
